UroGen Pharma Ltd. (URGN)

NASDAQ: URGN · IEX Real-Time Price · USD
14.96
-0.21 (-1.38%)
Mar 27, 2024, 4:00 PM EDT - Market closed

UroGen Pharma Market Cap

UroGen Pharma has a market cap or net worth of $510.47 million as of March 28, 2024. Its market cap has increased by 160.04% in one year.

Market Cap
510.47M
Enterprise Value
472.07M
1-Year Change
160.04%
Ranking
Category
Stock Price
$14.96

Market Cap Chart

Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $510.47M, an increase of 180.63%. That is a compound annual growth rate of 16.13%.

History

DateMarket Cap% Change
Mar 26, 2024517.60M-8.95%
Mar 25, 2024568.50M5.71%
Mar 22, 2024537.80M5.49%
Mar 21, 2024509.80M-0.14%
Mar 20, 2024510.50M-0.39%
Mar 19, 2024512.50M3.58%
Mar 18, 2024494.80M0.28%
Mar 15, 2024493.40M0.90%
Mar 14, 2024489.00M-9.31%
Mar 13, 2024539.20M-0.86%
Mar 12, 2024543.90M3.05%
Mar 11, 2024527.80M-4.95%
Mar 8, 2024555.30M-0.22%
Mar 7, 2024556.50M-0.11%
Mar 6, 2024557.10M0.22%
Mar 5, 2024555.90M-2.23%
Mar 4, 2024568.60M3.66%
Mar 1, 2024548.50M-3.06%
Feb 29, 2024565.80M0.89%
Feb 28, 2024560.80M-2.27%
Feb 27, 2024573.80M3.50%
Feb 26, 2024554.40M5.10%
Feb 23, 2024527.50M-3.93%
Feb 22, 2024549.10M0.57%
Feb 21, 2024546.00M-8.07%
View and export this data all the way back to 2017. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Dianthus Therapeutics 524.21M
PetIQ 523.58M
Lexicon Pharmaceuticals 522.02M
P3 Health Partners 521.75M
Mersana Therapeutics 521.60M
Cibus 517.63M
Solid Biosciences 512.74M
Phibro Animal Health 508.32M
Market Cap Rankings